semaglutide vs fasting Combining Intermittent and GLP-1s: What You Need to Know nejm Semaglutide, a glucagon-like peptide-1

In early 2023, semaglutide also gained FDA approval to treat obesity in pediatric patients aged 12 years and older [6, 7]

Particularly when you compare it to the risk of eye disease in the setting of diabetes, which is where most of this question has been studied

I havent done enough solo KPV only and nothing else to give a good sense for what thats doing independent of other treatments, but it does seem to enhance beyond where we were at prior to using it

second, most of the combination studies have been performed using exenatide, one of the least effective GLP-1RA in terms of HbA1c and body weight reduction

You can message the provider anytime if you have concerns or questions about side effects